Trial NCT04402723

View at ClinicalTrials.gov 
Org. Study IDs: ZGDAML1

Last trial update was posted on 2022-12-01

MeSH Interventions

Cytarabine Daunorubicin

MeSH Conditions

Leukemia, Myeloid, Acute

Other Conditions

Acute Myeloid Leukemia (AML)

Stopping Reasons

Corporate policy adjustments

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID